These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10349730)

  • 1. A diabetes switch?
    Gibbs WW
    Sci Am; 1999 Jun; 280(6):16. PubMed ID: 10349730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does inhibition of tyrosine phosphatase 1B protect from obesity and type 2 diabetes?].
    Ukkola O; Santaniemi M
    Duodecim; 2002; 118(18):1857-62. PubMed ID: 12422667
    [No Abstract]   [Full Text] [Related]  

  • 3. New clues found to diabetes and obesity.
    Ferber D
    Science; 1999 Mar; 283(5407):1423, 1425. PubMed ID: 10206863
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in protein tyrosine phosphatase 1B inhibitors.
    Taylor SD; Hill B
    Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase.
    Stanford SM; Aleshin AE; Zhang V; Ardecky RJ; Hedrick MP; Zou J; Ganji SR; Bliss MR; Yamamoto F; Bobkov AA; Kiselar J; Liu Y; Cadwell GW; Khare S; Yu J; Barquilla A; Chung TDY; Mustelin T; Schenk S; Bankston LA; Liddington RC; Pinkerton AB; Bottini N
    Nat Chem Biol; 2017 Jun; 13(6):624-632. PubMed ID: 28346406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance.
    Goldstein BJ
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2474-80. PubMed ID: 12050202
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
    Liu G; Trevillyan JM
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
    San Millán JL; Cortón M; Villuendas G; Sancho J; Peral B; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2640-6. PubMed ID: 15181035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of phosphotyrosine phosphatase (PTPase) 1B in insulin signalling.
    Worm D; Vinten J; Beck-Nielsen H
    Diabetologia; 1999 Sep; 42(9):1146-9. PubMed ID: 10447528
    [No Abstract]   [Full Text] [Related]  

  • 11. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
    Harley EA; Levens N
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of phosphatase inhibitors.
    Vintonyak VV; Antonchick AP; Rauh D; Waldmann H
    Curr Opin Chem Biol; 2009 Jun; 13(3):272-83. PubMed ID: 19410499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of protein tyrosine phosphatase-1B in diabetes and obesity.
    Kennedy BP
    Biomed Pharmacother; 1999 Dec; 53(10):466-70. PubMed ID: 10665340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance].
    Boduła A; Wdowczyk M; Adamiec R
    Postepy Hig Med Dosw (Online); 2005 May; 59():203-7. PubMed ID: 15928604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology evaluation: ISIS-113715, Isis.
    Liu G
    Curr Opin Mol Ther; 2004 Jun; 6(3):331-6. PubMed ID: 15264436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KK mouse.
    Ikeda H
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S313-6. PubMed ID: 7859626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Orally Bioavailable Purine-Based Inhibitors of the Low-Molecular-Weight Protein Tyrosine Phosphatase.
    Stanford SM; Diaz MA; Ardecky RJ; Zou J; Roosild T; Holmes ZJ; Nguyen TP; Hedrick MP; Rodiles S; Guan A; Grotegut S; Santelli E; Chung TDY; Jackson MR; Bottini N; Pinkerton AB
    J Med Chem; 2021 May; 64(9):5645-5653. PubMed ID: 33914534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obesity and type ii diabetes mellitus].
    Schmülling RM
    Internist (Berl); 1997 Mar; 38(3):224-30. PubMed ID: 9173043
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.
    Barr AJ
    Future Med Chem; 2010 Oct; 2(10):1563-76. PubMed ID: 21426149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.